SEC 13F Intelligence

Geneva Partners, LLC / MRK

Geneva Partners, LLC’s Merck & Co Inc Position

Does Geneva Partners, LLC own Merck & Co Inc (MRK)? Not currently — the last reported position was 21.2K shares worth $3M in Q2 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$3M
Q2 2024
Shares
21.2K
% of Portfolio
+1.08%
Quarters Held
8
position exited

Position History MRK

Reported value by quarter
Q3 ’22: $439,000Q3 ’22Q4 ’22: $6MQ4 ’22Q1 ’23: $5MQ1 ’23Q2 ’23: $6MQ2 ’23Q3 ’23: $4MQ3 ’23Q4 ’23: $2MQ4 ’23Q1 ’24: $3MQ1 ’24Q2 ’24: $3MQ2 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202421.2K$3M+1.08%
Q1 202420.2K$3M+1.18%
Q4 202320.5K$2M+1.24%
Q3 202341.9K$4M+2.86%
Q2 202350.1K$6M+3.77%
Q1 202351.2K$5M+4.67%
Q4 202253.4K$6M+5.59%
Q3 20225.1K$439,000+0.50%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Geneva Partners, LLC’s full portfolio or all institutional holders of MRK.